RxDoctor Payments Data

Dean Rich, DO

Family Medicine · Akron, OHNPI 1710925557

Payments from drug & device makers

$706in general payments, 2019–2025

Across 50 payments — averaging $14.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$260
  • Exact Sciences$105
  • AstraZeneca$85
  • Teva Pharmaceuticals USA, Inc.$53
  • Pfizer$41
  • Boehringer Ingelheim$41
  • plus $121 from 6 others

What the payments were for

  • Food & beverage$69198%
  • Education$152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$706 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$19,896
Medicare patients
105
Services billed
181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban117$80,772
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$38,861
Breo ElliptaFluticasone/Vilanterol62$30,802
Spiriva RespimatTiotropium Bromide29$21,800
XareltoRivaroxaban19$16,583
JanuviaSitagliptin Phosphate21$15,002
JardianceEmpagliflozin31$14,546
Spiriva HandihalerTiotropium Bromide26$14,308
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$9,479
EntrestoSacubitril/Valsartan14$9,458
FarxigaDapagliflozin Propanediol26$8,202
Albuterol Sulfate HfaAlbuterol Sulfate216$7,863
MyrbetriqMirabegron12$7,765
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$7,465
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$6,989

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$41$80,772117 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$260$79,142133 claims
Boehringer IngelheimSpiriva Respimat, Jardiance, Stiolto Respimat$41$43,81175 claims
AstraZenecaFarxiga, Symbicort$85$13,40637 claims
Astellas Pharma US IncMyrbetriq$18$7,76512 claims
Lilly USA, LLCHumalog$18$1,88924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Akron

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →